World Medicine, which continues its efforts to provide accessible and effective products globally, is launching the World Medicine Ophthalmology Scientific Advisory Board in Turkey through its eye health division, World Medicine Ophthalmics. This pioneering step is a first in the field. The board, composed of experts from sub-specialties in ophthalmology, consists of thought leaders who possess the knowledge and expertise to support the eye products in World Medicine's extensive product portfolio. The board plays a critical role in differentiating the company and its growth in the ophthalmology field in the market.
World Medicine Ophthalmics Turkey, the well-known brand in the eye products market of Turkey’s pharmaceutical export champion, World Medicine, is establishing the Ophthalmology Scientific Advisory Board to differentiate itself from competitors in terms of scientific strength and reliability. The advisory board, consisting of doctors from various hospitals, is a strong support and proof of the reliability and efficacy of World Medicine products. With this board’s assistance, World Medicine will be able to manage product development and improvement processes swiftly based on the feedback received.
Dr. Aytekin Bulut, Country Director of World Medicine Ophthalmics Turkey, stated, “As a young and dynamic team, our Ophthalmology Scientific Advisory Board brings together thought leaders in the field of ophthalmology within WMO Turkey. It serves as a consulting guide, equipped with the knowledge and expertise needed to support our entire product portfolio. With the clinical studies and research indicators from the board, our scientific foundations will be further strengthened.”
Dr. Aytekin Bulut pointed out that competitors need advisory boards when launching new products in specific therapeutic areas, saying, “We, on the other hand, have the opportunity to work shoulder to shoulder with our doctors whenever we need. Our board not only consists of influential doctors on both national and international platforms but also positions us as a more reliable entity in the eyes of the audience during board meetings, helping us stand out in the industry. With this collaboration, we are creating awareness in the sector through our online training programs.”
Innovative steps are our priority
Dr. Aytekin Bulut emphasized that since they started their operations in Turkey, they have always taken innovative steps to improve existing treatments and develop new products. He added, “With the foundations we’ve laid, we are confident that the World Medicine Ophthalmology Scientific Advisory Board will create an infrastructure that will help us achieve our long-term sustainable growth goals. This will be very valuable in strengthening our expertise in ophthalmology, ensuring sustainability, and differentiating ourselves.”
